Sign in

NCT07403201RecruitingEarly phase 1

The Effect of Therapy Combination in PCOS With Dlbs 3233

The Effect of Combination Therapy Dlbs 3233 and Clomifen Citrate vs Clomifen Citrate on Homa ir, Maturation Follicle, and Menstrual Cycle in PCOS Cases at Muhammadiyah Asri Medical Center Hospital

Source: ClinicalTrials.gov · Last updated 11 Feb 2026

Brief summary (registry, in English)

The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital

Status (registry)
Recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
90 (estimated)
First submitted
24 Nov 2021
Start date
15 Dec 2021
Primary completion date
31 Jan 2026
Lead sponsor
Inlacinpenelitian
NCT number
NCT07403201

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 90
  • From 15 Dec 2021 to the primary completion date, 31 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • dis agree to join research

Who the study is looking for

  • married agree to join this research

Age in the registry: - to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
RS AMC Yogyakarta
Coordinator of this site? Confirm its status
YogyakartaIndonesiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.